Faculty Opinions, an H1 community, opens up its content by providing free access to 235,000+ research article recommendations in its...
Optical enhancement company attends conference with eSight 4 user to demonstrate the technology and discuss the future of vision techFORT...
Healthcare Businesswomen’s Association Spotlights Kasey Boynton and Feni Komline for Biopharma Industry ImpactMORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) --...
The company launches with $9.5M in initial funding led by Target GlobalNEW YORK, May 10, 2022 (GLOBE NEWSWIRE) -- Reverence,...
The women-led healthtech company is recognized for its culture that focuses on the mental, emotional, physical and financial well-being of...
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...
REDWOOD CITY, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), announced today that senior management will...
ISELIN, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pre-commercial biopharmaceutical company working to develop...
Clearance allows for more access to non-drug, noninvasive treatment for patients suffering from MDD or OCDMALVERN, Pa., May 10, 2022...
Company to host conference call and webcast on, Wednesday, May 18that 8:30 am EDT LYON, France, May 10, 2022 -...
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell...
SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing...
CAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
PLACCINE DNA-based Vaccine in proof-of-concept non-Human Primate Studies Phase II study of GEN-1 in ovarian cancer 85% enrolled with full...
Data show that of the FURI study patients with refractory or relapsed vulvovaginal candidiasis (VVC) treated with ibrexafungerp, 71.4% had...
WEST PALM BEACH, FL, May 10, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians...
FREMONT, CA, May 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
AMITYVILLE, N.Y., May 10, 2022 (GLOBE NEWSWIRE) -- The Greenrose Holding Company Inc. (OTC: GNRS, GNRSW) (“Greenrose” or the “Company”),...
HONG KONG, May 10, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
Dose Escalation Portion of NXP800 Phase 1 Study is Ongoing NXP800 Unique Discovery and Optimization Program Showcased at the 2022...
